Mirae Asset Global Investments Co., Ltd. Recursion Pharmaceuticals, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $37.3 Billion
- Q1 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 13,220 shares of RXRX stock, worth $55,259. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13,220
Previous 12,721
3.92%
Holding current value
$55,259
Previous $85,000
18.82%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding RXRX
# of Institutions
365Shares Held
286MCall Options Held
3.28MPut Options Held
3.16M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl34.8MShares$146 Million1.99% of portfolio
-
Vanguard Group Inc Valley Forge, PA32.3MShares$135 Million0.0% of portfolio
-
Baillie Gifford & CO24.4MShares$102 Million0.12% of portfolio
-
Black Rock Inc. New York, NY17.3MShares$72.4 Million0.0% of portfolio
-
Softbank Group Corp Minato Ku Tokyo, M014.7MShares$61.3 Million0.27% of portfolio
About RECURSION PHARMACEUTICALS, INC.
- Ticker RXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 180,480,000
- Market Cap $754M
- Description
- Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...